We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protein Identified Modifies Gene Expression in Response to Mitochondrial Damage

By LabMedica International staff writers
Posted on 03 Jan 2017
Print article
Image: A proposed model of hnRNPA2 (in gray) shows where acetyl-CoA (green) can \"dock\" and interact with different components of the protein. These interactions allow it to transfer acetyl-CoA groups to nuclear gene promoters and translate mitochondrial stress to nuclear gene activation, a process associated with cancer progression (Photo courtesy of the University of Pennsylvania).
Image: A proposed model of hnRNPA2 (in gray) shows where acetyl-CoA (green) can \"dock\" and interact with different components of the protein. These interactions allow it to transfer acetyl-CoA groups to nuclear gene promoters and translate mitochondrial stress to nuclear gene activation, a process associated with cancer progression (Photo courtesy of the University of Pennsylvania).
A protein has been identified that causes changes in cellular gene expression in response to stress or disease related impairment in mitochondrial function.

Reduced mitochondrial DNA copy number, mitochondrial DNA mutations or disruption of electron transfer chain complexes induce mitochondria-to-nucleus retrograde signaling, which induces global change in nuclear gene expression ultimately contributing to various human pathologies including cancer. Recent studies suggested that these mitochondrial changes caused transcriptional reprogramming of nuclear genes although the mechanism of this cross talk was not clarified.

Investigators at the University of Pennsylvania (Philadelphia, USA) recently described a mechanism by which mitochondria could drive changes in nuclear gene expression that were associated with tumor progression. They reported in the December 6, 2016, online edition of the journal Cell Discovery that mitochondria-to-nucleus retrograde signaling regulated chromatin acetylation and altered nuclear gene expression through the activity of the protein hnRNAP2 (heterogeneous ribonucleoprotein A2).

To evaluate the role of hnRNPA2 in mitochondria-to-nucleus communication, the investigators traced its activity in cells with depleted levels of mitochondria. Results showed that hnRNPA2 activated gene promoters of stress-associated genes in the nucleus by binding to them. Furthermore, hnRNPA2 activated these genes by acetylating a histone, which loosened the tightly packed chromatin, allowing DNA transcription to proceed more readily. These processes were reversed when mitochondrial DNA content was restored to near normal cell levels.

These findings suggest an important role for mitochondria as determinants of cell fate by altering the expression of large sets of nuclear genes through epigenetic mechanisms.

"Our study provides a rigorous demonstration of a link between mitochondrial function and nuclear gene expression," said senior author Dr. Narayan Avadhani, professor of biochemistry at the University of Pennsylvania. "Since we know that this type of signaling has a direct role in the early stages of cancer progression, the protein involved could be a very valuable target for alleviating this signaling and possibly cancer progression."

Related Links:
University of Pennsylvania

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.